Real-world treatment landscape in advanced metastatic castration resistant prostate cancer

被引：0
|
作者：
Sacchi, Elizabeth
Singhal, Hari
Zamalloa, Jose
Sanchez, Beatriz Lopez
Zhang, Ke
Parihar, Harish
Greshock, Joel
Max, Steven I.
机构：
[1] Johnson & Johnson Innovat Med, Cambridge, MA USA
[2] Janssen Res & Dev, San Francisco, CA USA
[3] Johnson & Johnson Innovat Med, Lawrence, NJ USA
[4] Johnson & Johnson Innovat Med, Leiden, Netherlands
[5] Janssen Res & Dev La Jolla, San Diego, CA USA
[6] Janssen Pharmaceut, Clovis, CA USA
[7] Johnson & Johnson Innovat Med, Res & Dev, Raritan, NJ USA
[8] Janssen Pharmaceut Inc, Spring House, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17032
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Outcomes and toxicity of oral Fosfestrol in metastatic castration-resistant prostate cancer-a real-world experience
    Devi, R. Nandini
    Shenoy, V. P. Praveen Kumar
    Ismail, Irshad
    Avaronnan, Manuprasad
    ECANCERMEDICALSCIENCE, 2023, 17
  • [42] Real-world patterns of genomic testing in patients (Pts) with metastatic castration-resistant prostate cancer (mCRPC)
    Shore, N.
    Ionescu-Ittu, R.
    Yang, L.
    Laliberte, F.
    Payne, S.
    Gayle, A.
    Amin, S.
    Mahendran, M.
    Lejeune, D.
    Yu, L.
    Burgents, J.
    Duh, M. S.
    Ghate, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S526 - S527
  • [43] Real-world first-line systemic therapy patterns in metastatic castration-resistant prostate cancer
    Anton, Angelyn
    Pillai, Sruti
    Semira, Marie Christine
    Wong, Shirley
    Shapiro, Julia
    Weickhardt, Andrew
    Azad, Arun
    Kwan, Edmond M.
    Spain, Lavinia
    Gunjur, Ashray
    Torres, Javier
    Parente, Phillip
    Parnis, Francis
    Goh, Jeffrey
    Baenziger, Olivia
    Gibbs, Peter
    Tran, Ben
    BJUI COMPASS, 2022, 3 (03): : 205 - 213
  • [44] A real-world registry of patients with metastatic castration-resistant prostate cancer (mCRPC): REMPRO study.
    Gonzalez, Francisco
    Kodagali, Rohit
    Tung, Teresa
    Masoud, Mohamed
    Rajadhyaksha, Viraj
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [45] Abiraterone acetate and prednisone in metastatic castration-resistant prostate cancer: a real-world retrospective study in China
    Liu, Min
    Yan, Jiaqing
    Le, Kaidi
    Li, Ying
    Xing, Nianzeng
    Li, Guohui
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [46] A multicenter observational study of the real-world use of docetaxel for metastatic castration-resistant prostate cancer in China
    He, Dalin
    Sun, Zhongquan
    Guo, Jianming
    Zhang, Zhigen
    Shan, Yuxi
    Ma, Lulin
    Li, Hanzhong
    Jin, Jie
    Huang, Yiran
    Xiao, Jiaquan
    Wei, Qiang
    Ye, Dingwei
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 (03) : 144 - 150
  • [47] COMPARISON OF THE CARDIOTOXICITY OF ABIRATERONE AND ENZALUTAMIDE IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER USING REAL-WORLD DATA
    Hu, Jason
    Aprikian, Armen
    Vanhuyse, Marie
    Dragomir, Alice
    JOURNAL OF UROLOGY, 2021, 206 : E418 - E419
  • [48] Real-world assessment of AR-LBD mutations in metastatic castration-resistant prostate cancer.
    Antonarakis, Emmanuel S.
    Zhang, Nicole
    Saha, Jayati
    Nevalaita, Liina
    Shell, Scott A.
    Garratt, Chris
    Ikonen, Tarja
    Fizazi, Karim
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [49] Treatment intensification in metastatic castration-sensitive prostate cancer: a real-world study in Alberta, Canada
    Yip, Steven M.
    Cheung, Winson Y.
    Aprikian, Armen
    Stoelzel, Matthias
    Wong, Kelvin
    Pranzo, Alessandra
    Mclean, Thomas
    O'Sullivan, Dylan E.
    Chilelli, Andrew
    FUTURE ONCOLOGY, 2025,
  • [50] Treatment patterns of metastatic castration-sensitive prostate cancer (mCSPC): A real-world evidence study
    Tagawa, S. T.
    Sandin, R.
    Sah, J.
    Mu, Q.
    Freedland, S. J.
    ANNALS OF ONCOLOGY, 2020, 31 : S541 - S542
12345